Samia Martin

1.4k total citations
16 papers, 637 citations indexed

About

Samia Martin is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Samia Martin has authored 16 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Genetics and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Samia Martin's work include Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (4 papers) and CRISPR and Genetic Engineering (3 papers). Samia Martin is often cited by papers focused on Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (4 papers) and CRISPR and Genetic Engineering (3 papers). Samia Martin collaborates with scholars based in France, United States and Italy. Samia Martin's co-authors include Olivier Danos, Yasuhiro Takeuchi, Jonathan P. Stoye, Greg J. Towers, Michael Bock, P. Véron, Anne Galy, David Fenard, Carole Masurier and Christian Leborgne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Samia Martin

15 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samia Martin France 13 375 276 166 148 108 16 637
Randall K. Merling United States 15 382 1.0× 201 0.7× 159 1.0× 221 1.5× 80 0.7× 20 667
Ashley I. Beyer United States 14 806 2.1× 210 0.8× 65 0.4× 91 0.6× 108 1.0× 17 1.1k
Yi Zuo United States 8 710 1.9× 303 1.1× 77 0.5× 115 0.8× 219 2.0× 8 993
Joanne C. Griffiths United Kingdom 5 334 0.9× 317 1.1× 161 1.0× 128 0.9× 195 1.8× 5 705
Saswati Chatterjee United States 13 376 1.0× 340 1.2× 61 0.4× 60 0.4× 58 0.5× 18 516
Megan L. Schultz United States 9 298 0.8× 108 0.4× 149 0.9× 105 0.7× 75 0.7× 13 477
Shu Mi China 12 329 0.9× 171 0.6× 146 0.9× 206 1.4× 64 0.6× 22 636
Tsanan Giroglou Germany 12 379 1.0× 414 1.5× 95 0.6× 90 0.6× 111 1.0× 17 730
Naoto Inukai Japan 10 1.0k 2.7× 122 0.4× 98 0.6× 111 0.8× 127 1.2× 13 1.2k
Claudia Firrito Italy 4 393 1.0× 224 0.8× 62 0.4× 70 0.5× 58 0.5× 8 515

Countries citing papers authored by Samia Martin

Since Specialization
Citations

This map shows the geographic impact of Samia Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samia Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samia Martin more than expected).

Fields of papers citing papers by Samia Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samia Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samia Martin. The network helps show where Samia Martin may publish in the future.

Co-authorship network of co-authors of Samia Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Samia Martin. A scholar is included among the top collaborators of Samia Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samia Martin. Samia Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Poletti, Valentina, Fabrizia Urbinati, Sabine Charrier, et al.. (2018). Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease. Molecular Therapy — Methods & Clinical Development. 11. 167–179. 18 indexed citations
2.
Danièle, Nathalie, Laura Julien, Martina Marinello, et al.. (2018). Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice. Journal of Neuropathology & Experimental Neurology. 77(4). 282–295. 10 indexed citations
3.
Durand, Amandine, Fernando E. Sepulveda, Julie Rivière, et al.. (2017). Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency. Blood Advances. 1(27). 2781–2789. 21 indexed citations
4.
Matet, Alexandre, Corinne Kostic, Alexis‐Pierre Bemelmans, et al.. (2017). Evaluation of tolerance to lentiviral LV-RPE65 gene therapy vector after subretinal delivery in non-human primates. Translational research. 188. 40–57.e4. 18 indexed citations
5.
Lattanzi, Annalisa, Stéphanie Duguez, Arianna Moiani, et al.. (2017). Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System. Molecular Therapy — Nucleic Acids. 7. 11–19. 41 indexed citations
6.
Ronzitti, Giuseppe, Giulia Bortolussi, Remco van Dijk, et al.. (2016). A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome. Molecular Therapy — Methods & Clinical Development. 3. 16049–16049. 48 indexed citations
7.
Armbruster, Nicole, Annalisa Lattanzi, Laetitia van Wittenberghe, et al.. (2016). Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy. Molecular Therapy — Methods & Clinical Development. 3. 16060–16060. 39 indexed citations
8.
Poletti, Valentina, Sabine Charrier, Samia Martin, et al.. (2016). Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1). Blood. 128(22). 4705–4705. 1 indexed citations
9.
Scrudato, Mirella Lo, Samia Martin, Geneviève Gourdon, Denis Furling, & Ana Buj‐Bello. (2016). 322. Genome Editing for Nucleotide Repeat Disorders: Towards a New Therapeutic Approach for Myotonic Dystrophy Type 1. Molecular Therapy. 24. S129–S130. 1 indexed citations
10.
Majdoul, Saliha, et al.. (2014). Influence of Mildly Acidic pH Conditions on the Production of Lentiviral and Retroviral Vectors. PubMed. 25(3). 178–185. 17 indexed citations
11.
Fenard, David, et al.. (2013). Infectivity enhancement of different HIV-1-based lentiviral pseudotypes in presence of the cationic amphipathic peptide LAH4-L1. Journal of Virological Methods. 189(2). 375–378. 19 indexed citations
12.
Fenard, David, et al.. (2013). Vectofusin-1, a New Viral Entry Enhancer, Strongly Promotes Lentiviral Transduction of Human Hematopoietic Stem Cells. Molecular Therapy — Nucleic Acids. 2. e90–e90. 56 indexed citations
13.
Véron, P., et al.. (2012). Humoral and Cellular Capsid-Specific Immune Responses to Adeno-Associated Virus Type 1 in Randomized Healthy Donors. The Journal of Immunology. 188(12). 6418–6424. 70 indexed citations
14.
Véron, P., Sylvie Boutin, Samia Martin, et al.. (2009). Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation. Journal of Translational Medicine. 7(1). 10–10. 18 indexed citations
15.
Bartoli, Marc, Carinne Roudaut, Samia Martin, et al.. (2005). Safety and Efficacy of AAV-Mediated Calpain 3 Gene Transfer in a Mouse Model of Limb-Girdle Muscular Dystrophy Type 2A. Molecular Therapy. 13(2). 250–259. 57 indexed citations
16.
Towers, Greg J., Michael Bock, Samia Martin, et al.. (2000). A conserved mechanism of retrovirus restriction in mammals. Proceedings of the National Academy of Sciences. 97(22). 12295–12299. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Randall K. Merling Breakdown of academic impact, for papers by Ashley I. Beyer Breakdown of academic impact, for papers by Yi Zuo Breakdown of academic impact, for papers by Joanne C. Griffiths Breakdown of academic impact, for papers by Saswati Chatterjee Breakdown of academic impact, for papers by Megan L. Schultz Breakdown of academic impact, for papers by Shu Mi Breakdown of academic impact, for papers by Tsanan Giroglou Breakdown of academic impact, for papers by Naoto Inukai Breakdown of academic impact, for papers by Claudia Firrito
Rankless by CCL
2026